Massachusetts Financial Services
WST icon

Massachusetts Financial Services’s West Pharmaceutical WST Stock Holding History

Massachusetts Financial Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-577,417
Closed -$173M – 930
2024
Q3 		$173M Sell
577,417
-59,156
-9% -$18.1M 0.05% 304
2024
Q2 		$210M Sell
636,573
-88,644
-12% -$31.3M 0.06% 256
2024
Q1 		$287M Buy
725,217
+62,082
+9% +$23M 0.09% 210
2023
Q4 		$234M Buy
663,135
+90,092
+16% +$31.9M 0.08% 226
2023
Q3 		$215M Buy
+573,043
New +$222M 0.08% 229
2022
Q4 		– Sell
-322,183
Closed -$79.3M – 892
2022
Q3 		$79.3M Sell
322,183
-290,708
-47% -$88.6M 0.03% 371
2022
Q2 		$185M Sell
612,891
-128,990
-17% -$42M 0.06% 257
2022
Q1 		$305M Buy
741,881
+11,569
+2% +$4.53M 0.09% 200
2021
Q4 		$343M Buy
730,312
+7,995
+1% +$3.44M 0.09% 191
2021
Q3 		$307M Sell
722,317
-16,230
-2% -$6.84M 0.09% 199
2021
Q2 		$265M Buy
738,547
+2,547
+0.3% +$842K 0.08% 217
2021
Q1 		$207M Buy
736,000
+12,172
+2% +$3.48M 0.06% 253
2020
Q4 		$205M Buy
723,828
+64,507
+10% +$18.1M 0.07% 245
2020
Q3 		$181M Buy
659,321
+172,414
+35% +$45.6M 0.07% 230
2020
Q2 		$111M Buy
486,907
+1,507
+0.3% +$296K 0.04% 299
2020
Q1 		$73.9M Sell
485,400
-444,173
-48% -$68.4M 0.04% 316
2019
Q4 		$140M Sell
929,573
-10,049
-1% -$1.46M 0.05% 262
2019
Q3 		$133M Sell
939,622
-30,310
-3% -$4.17M 0.05% 262
2019
Q2 		$121M Buy
969,932
+56,075
+6% +$6.62M 0.05% 274
2019
Q1 		$101M Buy
913,857
+222,355
+32% +$23.1M 0.04% 287
2018
Q4 		$67.8M Buy
691,502
+159,814
+30% +$17.3M 0.03% 338
2018
Q3 		$65.6M Buy
531,688
+333,130
+168% +$37.4M 0.03% 364
2018
Q2 		$19.7M Buy
198,558
+13,717
+7% +$1.26M 0.01% 516
2018
Q1 		$16.3M Buy
184,841
+39,718
+27% +$3.72M 0.01% 530
2017
Q4 		$14.3M Sell
145,123
-14,257
-9% -$1.4M 0.01% 565
2017
Q3 		$15.3M Buy
+159,380
New +$14.4M 0.01% 538

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Massachusetts Financial Services's WST Position: Q4 2024 in Review

Massachusetts Financial Services sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 577,417 shares — an estimated $173M sold.

Massachusetts Financial Services first reported a position in WST in Q3 2017 and held it in 26 quarters. The position peaked at $343M in Q4 2021. 747 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Massachusetts Financial Services reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 577,417 West Pharmaceutical shares in Q4 2024, an estimated $173M.
  • Massachusetts Financial Services first reported a position in West Pharmaceutical in Q3 2017 and held it in 26 quarters.
  • Massachusetts Financial Services's West Pharmaceutical position peaked at $343M in Q4 2021.
  • 747 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Massachusetts Financial Services's 13F filing for Q4 2024, filed 12 Feb 2025.